ANNX · Annexin Pharmaceuticals AB (publ) · Insider Trading
Transactions in Annexin Pharmaceuticals AB (publ) securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-07-09 | Curt Mikael von Euler-Chelpin Member of the Board of Directors · Related person: | Subscription | Annexin Pharmaceuticals AB BTA · SE0009664154 | 5000 Quantity | 12 SEK | Current |
| 2026-07-07 | Mikael Lönn Member of the Board of Directors · Related person: | Allotment | ANNX BTA BTA · SE0029300896 | 435978 Quantity | 12 SEK | Current |
| 2025-03-24 | Anna Frostegård Other senior executive · Related person: | Acquisition | Annexin Pharmaceuticals AB BTA · SE0024173066 | 2747355 Quantity | 0.3 SEK | Current |
| 2025-03-24 | Mikael Lönn Member of the Board of Directors · Related person: | Allotment | Annexin BTA BTA · SE0024173066 | 43251795 Quantity | 0.3 SEK | Current |
| 2024-10-23 | Anna Frostegård Other senior executive · Related person: | Acquisition | ANnexin Teckningsoption 2024/2027:1 Subcription warrant · | 5000000 Quantity | 0.1 SEK | Current |
| 2024-10-23 | Susan Suchdev Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Annexin Teckningsoption 2024/2027:1 Subcription warrant · | 900000 Quantity | 0.1 SEK | Current |
| 2024-10-23 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | Annexin Teckningsoption 2024/2027:1 Subcription warrant · | 5000000 Quantity | 0.1 SEK | Current |
| 2024-10-23 | Susanne Andersson Chief Financial Officer (CFO) · Related person: | Acquisition | Annexin Teckningsoption 2024/2027:1 Subcription warrant · | 300000 Quantity | 0.1 SEK | Current |
| 2024-10-23 | Jan Nilsson Chairman of the Board of Directors · Related person: | Acquisition | Annexin Teckningsoption 2024/2027:1 Subcription warrant · | 200000 Quantity | 0.1 SEK | Current |
| 2024-07-03 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 145600 Quantity | 0.25 SEK | Current |
| 2024-07-03 | Mikael Lönn Member of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 560000 Quantity | 0.25 SEK | Current |
| 2024-06-12 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | Annexin Pharmaceuticals AB BTA · SE0022087375 | 192055 Quantity | 0.25 SEK | Current |
| 2024-06-04 | Curt Mikael von Euler-Chelpin Member of the Board of Directors · Related person: | Subscription | ANNX BTA · SE0022087375 | 240000 Quantity | 0.25 SEK | Current ISIN numret var inte korrekt och instrument ska vara BTA2. Så jag har valt BTA hoppas att det blir rätt. |
| 2024-06-05 | Mikael Lönn Member of the Board of Directors · Related person: | Acquisition | BTA2 BTA · SE0022087375 | 1477343 Quantity | 0.25 SEK | Current |
| 2024-06-04 | Curt Mikael von Euler-Chelpin Member of the Board of Directors · Related person: | Subscription | ANNX Share · SE0009664154 | 240000 Quantity | 0.25 SEK | Revised |
| 2024-05-28 | Mikael Lönn Member of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB BTU BTA · SE0017070865 | 46652346 Quantity | 0.25 SEK | Current |
| 2024-05-29 | Carl-Fredrik Lindner Member of the Board of Directors · Related person: | Acquisition | ANNX BTA BTA · SE0022087367 | 399997 Quantity | 0.25 SEK | Current |
| 2024-05-28 | Anna Frostegård Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Annexin Pharmaceuticals AB BTA · SE0022087367 | 3007628 Quantity | 0.25 SEK | Current ändrat ISIN koden |
| 2024-05-28 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | Annexin Pharmaceuticals AB BTA · SE0022087367 | 512200 Quantity | 0.25 SEK | Current |
| 2024-05-28 | Anna Frostegård Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Annexin Pharmaceuticals AB BTA · SE0009664154 | 3007628 Quantity | 0.25 SEK | Revised |
| 2023-12-14 | Uli Hacksell Chairman of the Board of Directors · Related person: | Allotment | ANNX BTA BTA · SE0021148707 | 110000 Quantity | 0.2 SEK | Current |
| 2023-12-18 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | ANNX BTA BTA · SE0021148707 | 635008 Quantity | 0.2 SEK | Current |
| 2023-12-18 | Anna Frostegård Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Annexin Pharmaceuticals AB BTA · SE0009664154 | 2910622 Quantity | 0.2 SEK | Current |
| 2023-12-15 | Carl-Fredrik Lindner Member of the Board of Directors · Related person: | Acquisition | ANNX TR Subscription right/Unit right · SE0021148699 | 500005 Quantity | 0.2 SEK | Current |
| 2022-06-14 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | 2022/2025 Subcription warrant · | 300000 Quantity | 0.21 SEK | Current |
| 2022-03-15 | Uli Hacksell Chairman of the Board of Directors · Related person: | Acquisition | ANNX.ST Share · SE0009664154 | 100000 Quantity | 0.869 SEK | Current ISIN kod och handelsplats |
| 2022-03-15 | Uli Hacksell Chairman of the Board of Directors · Related person: | Acquisition | ANNX.ST Share · SE0017070899 | 100000 Quantity | 0.869 SEK | Revised |
| 2021-11-03 | Carl-Fredrik Lindner Member of the Board of Directors · Related person: | Subscription | Annexin Pharmaceuticals AB BTU · SE0009664154 | 60000 Quantity | 1.25 SEK | Current |
| 2021-10-25 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | Annexin Pharmaceuticals AB BTU BTU · SE0017070865 | 150000 Quantity | 1.25 SEK | Current Transaktionens karaktär: Från "förvärv" till "teckning" |
| 2021-10-22 | Henrik Palm Chief Financial Officer (CFO) · Related person: | Subscription | Annexin Pharmaceuticals AB BTU BTU · SE0009664154 | 75000 Quantity | 1.25 SEK | Current Plats för transaktionen - Från "FIRST NORTH SWEDEN - SME GROWTH MARKET" till "Utanför handelsplats" |
| 2021-10-25 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | Annexin Pharmaceuticals AB BTU BTU · SE0017070865 | 150000 Quantity | 1.25 SEK | Revised |
| 2021-10-25 | Lena Torlegård Member of the Board of Directors · Related person: | Subscription | Annexin Pharmaceuticals AB BTU BTU · SE0017070865 | 75000 Quantity | 1.25 SEK | Current |
| 2021-10-22 | Henrik Palm Chief Financial Officer (CFO) · Related person: | Subscription | Annexin Pharmaceuticals AB BTU BTU · SE0009664154 | 75000 Quantity | 1.25 SEK | Revised |
| 2021-01-07 | Nils Anders Haegerstrand Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | 2020/2023 Subcription warrant · | 164761 Quantity | 0.32 SEK | Current |
| 2020-12-23 | Carl-Fredrik Lindner Chairman of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 29998 Quantity | 1.78 SEK | Current |
| 2020-12-23 | Carl-Fredrik Lindner Chairman of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 3000 Quantity | 1.78 SEK | Current |
| 2020-12-23 | Carl-Fredrik Lindner Chairman of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 40688 Quantity | 1.8 SEK | Current |
| 2020-12-23 | Carl-Fredrik Lindner Chairman of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 2145 Quantity | 1.795 SEK | Current |
| 2020-12-23 | Carl-Fredrik Lindner Chairman of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 2169 Quantity | 1.775 SEK | Current |
| 2020-12-23 | Carl-Fredrik Lindner Chairman of the Board of Directors · Related person: | Acquisition | Annexin Pharmaceuticals AB Share · SE0009664154 | 2000 Quantity | 1.77 SEK | Current |
| 2020-07-17 | Nils Anders Haegerstrand VD · Related person: | Acquisition | 2020/2023 Subcription warrant · | 1250000 Quantity | 0.4 SEK | Current |
| 2020-07-17 | Henrik Palm Ekonomi/finanschef · Related person: | Acquisition | 2020/2023 Subcription warrant · | 235758 Quantity | 0.4 SEK | Current |
| 2020-03-06 | Henrik Palm Ekonomi/finanschef · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 10000 Quantity | 1.2 SEK | Current |
| 2020-03-05 | Henrik Palm Ekonomi/finanschef · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 25000 Quantity | 1.3 SEK | Current |
| 2020-03-05 | Henrik Palm Ekonomi/finanschef · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 2286 Quantity | 1.3 SEK | Current |
| 2020-03-05 | Henrik Palm Ekonomi/finanschef · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 10000 Quantity | 1.3 SEK | Current |
| 2020-03-03 | Henrik Palm Ekonomi/finanschef · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 18000 Quantity | 1.3 SEK | Current |
| 2020-03-03 | Henrik Palm Ekonomi/finanschef · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 2714 Quantity | 1.26 SEK | Current |
| 2020-03-02 | Susan Suchdev COO · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 36855 Quantity | 1.3 SEK | Cancelled Överstiger ej 5000 Euro |
| 2020-03-02 | Susan Suchdev COO · Related person: | Acquisition | Annexin Pharmaceuticals BTA BTA · SE0013748894 | 36855 Quantity | 1.3 SEK | Cancelled |
3746 publication days captured; dates between 2016-07-03 and 2026-10-06 may contain gaps. Checked 2026-10-07 11:08 UTC.